Metabolic Alkalosis

Metabolic alkalosis is a primary acid-base disturbance characterized by an elevation in plasma bicarbonate (HCO3-) concentration, typically accompanied by a compensatory increase in arterial partial pressure of carbon dioxide (PaCO2) via alveolar hypoventilation. It is defined by an arterial blood pH greater than 7.45, a plasma bicarbonate concentration greater than 26 mmol/L (in dogs and cats), and a base excess greater than +4 mmol/L. The condition arises from either a net gain of bicarbonate or a net loss of hydrogen ions (H+) from the extracellular fluid. Metabolic alkalosis is one of the most common acid-base disorders in veterinary patients, particularly in those with gastrointestinal disease, diuretic therapy, or hyperadrenocorticism. It can be classified as chloride-responsive (urine chloride < 20 mEq/L) or chloride-resistant (urine chloride > 20 mEq/L), which guides therapeutic intervention. The disorder can be acute or chronic, and its severity ranges from mild, clinically silent cases to life-threatening systemic derangements, including cardiac arrhythmias, neuromuscular irritability, and altered mental status. Understanding the underlying pathophysiology is essential for effective management, as correction of the primary cause is paramount.

The etiologies of metabolic alkalosis in veterinary medicine are diverse and can be categorized based on the underlying mechanism: hydrogen ion loss, bicarbonate retention, or contraction alkalosis. Common causes include: 1) Gastrointestinal hydrogen ion loss: Vomiting of gastric contents (e.g., due to gastritis, gastric outflow obstruction, or dietary indiscretion) leads to loss of hydrochloric acid, resulting in alkalosis. 2) Renal hydrogen ion loss: Excessive renal excretion of hydrogen ions occurs with loop diuretics (e.g., furosemide) and thiazide diuretics, which increase distal sodium delivery and enhance hydrogen ion secretion. 3) Mineralocorticoid excess: Hyperadrenocorticism (Cushing's syndrome) or primary hyperaldosteronism (Conn's syndrome) causes increased renal hydrogen ion and potassium secretion, leading to metabolic alkalosis. 4) Hypokalemia: Potassium depletion can cause intracellular shift of hydrogen ions and increased renal hydrogen ion secretion, perpetuating alkalosis. 5) Bicarbonate administration: Iatrogenic administration of sodium bicarbonate (e.g., during cardiopulmonary resuscitation or treatment of metabolic acidosis) can cause alkalosis if excessive. 6) Contraction alkalosis: Loss of extracellular fluid without proportional loss of bicarbonate (e.g., due to diuretics or vomiting) concentrates the remaining bicarbonate. 7) Post-hypercapnic alkalosis: Chronic respiratory acidosis (elevated PaCO2) leads to compensatory renal bicarbonate retention; rapid correction of hypercapnia (e.g., mechanical ventilation) can leave a transient metabolic alkalosis. 8) Liver disease: Hepatic failure can cause alkalosis due to impaired urea synthesis and increased ammonia buffering. 9) Genetic disorders: Rare congenital defects in renal tubular transport (e.g., Bartter syndrome) have been reported in humans and may occur in animals. Each etiology requires specific diagnostic and therapeutic considerations.

Metabolic alkalosis is a common acid-base disorder in dogs and cats, though exact prevalence data are limited. It is frequently encountered in emergency and critical care settings, particularly in patients with gastrointestinal disease (e.g., vomiting due to pancreatitis, parvovirus, or gastric dilatation-volvulus) and in those receiving diuretic therapy. There is no strong breed or sex predisposition, but certain conditions that cause alkalosis have breed associations: for example, hyperadrenocorticism is more common in Poodles, Dachshunds, and Boxers; primary hyperaldosteronism is more common in cats, especially older cats. Age distribution reflects the underlying disease: young animals may present with vomiting due to infectious causes, while older animals are more likely to have endocrine disorders or chronic kidney disease. Geographic variation is minimal, but seasonal patterns may influence the incidence of certain infectious causes of vomiting. In hospitalized patients, the prevalence of metabolic alkalosis has been reported to be as high as 30-50% in some critical care populations, often as a complication of therapy (e.g., nasogastric suction, diuretics). The condition is often underdiagnosed because mild cases may be asymptomatic and blood gas analysis is not routinely performed in all patients.

The pathophysiology of metabolic alkalosis involves a complex interplay of renal and extrarenal mechanisms. The primary disturbance is an increase in plasma bicarbonate concentration, which can result from: 1) Loss of hydrogen ions: Hydrogen ions are lost via the gastrointestinal tract (vomiting) or the kidneys (diuretics, mineralocorticoid excess). Loss of hydrogen ions from the stomach occurs with vomiting of gastric contents, which are rich in hydrochloric acid. Renal hydrogen ion loss occurs in the distal nephron, where hydrogen ion secretion is stimulated by aldosterone, hypokalemia, or increased distal sodium delivery. 2) Bicarbonate retention: This can occur due to excessive bicarbonate administration or renal retention of bicarbonate, often as a compensatory response to chronic respiratory acidosis. 3) Contraction alkalosis: Loss of extracellular fluid without proportional loss of bicarbonate (e.g., due to diuretics) concentrates the remaining bicarbonate, raising its concentration. The body attempts to compensate for metabolic alkalosis through respiratory and renal mechanisms. Respiratory compensation involves alveolar hypoventilation, which increases PaCO2 and helps normalize pH. However, this compensation is limited by hypoxia and is often incomplete. Renal compensation involves increased excretion of bicarbonate in the urine, but this is impaired in the presence of hypokalemia, hypochloremia, or volume depletion, which stimulate renal hydrogen ion reabsorption. The maintenance of metabolic alkalosis is critical: even if the initial cause is removed, the alkalosis may persist if factors such as hypokalemia, hypochloremia, or volume depletion are not corrected. These factors enhance renal hydrogen ion secretion and bicarbonate reabsorption, perpetuating the alkalosis. Systemic effects of metabolic alkalosis include: 1) Neuromuscular irritability: Alkalosis increases neuronal excitability, leading to muscle twitching, tremors, and seizures. 2) Cardiac arrhythmias: Alkalosis can cause hypokalemia and hypocalcemia, which predispose to arrhythmias. 3) Hypoventilation: Compensatory hypoventilation can lead to hypoxemia in patients with underlying pulmonary disease. 4) Electrolyte disturbances: Hypokalemia and hypochloremia are common and can exacerbate the alkalosis. 5) Impaired oxygen delivery: Alkalosis shifts the oxyhemoglobin dissociation curve to the left, increasing hemoglobin's affinity for oxygen and reducing oxygen release to tissues.

Several factors predispose animals to the development of metabolic alkalosis. Intrinsic factors include: 1) Age: Young animals are more susceptible to fluid and electrolyte losses due to vomiting and diarrhea. 2) Breed: Certain breeds are predisposed to conditions that cause alkalosis, such as hyperadrenocorticism (e.g., Poodles, Dachshunds) and primary hyperaldosteronism (cats). 3) Genetic mutations: Rare genetic defects in renal transporters (e.g., Bartter syndrome) can cause alkalosis. 4) Concurrent diseases: Chronic kidney disease, liver disease, and heart failure can predispose to alkalosis due to diuretic use or altered acid-base regulation. Extrinsic factors include: 1) Medications: Loop diuretics (furosemide), thiazide diuretics, and mineralocorticoids (fludrocortisone) can cause alkalosis. 2) Dietary factors: High-protein diets can increase acid load, but this is not a common cause of alkalosis. 3) Iatrogenic factors: Excessive sodium bicarbonate administration, nasogastric suction, and rapid correction of hypercapnia can precipitate alkalosis. 4) Management factors: Inadequate fluid therapy in vomiting patients can lead to volume depletion and contraction alkalosis. 5) Stress: Stress can increase endogenous corticosteroid production, potentially contributing to alkalosis in susceptible animals.

Clinical signs of metabolic alkalosis are often related to the underlying cause and the severity of the acid-base disturbance. In mild cases, animals may be asymptomatic. As alkalosis progresses, signs may include: 1) Neuromuscular signs: Muscle weakness, tremors, twitching, and in severe cases, seizures. These are due to increased neuronal excitability and hypocalcemia. 2) Cardiovascular signs: Cardiac arrhythmias (e.g., ventricular premature contractions, tachycardia) may occur, especially if hypokalemia is present. 3) Respiratory signs: Compensatory hypoventilation may lead to shallow, slow breathing, and in patients with underlying pulmonary disease, hypoxemia. 4) Gastrointestinal signs: Vomiting (if the cause is gastrointestinal) or anorexia, nausea, and constipation. 5) Renal signs: Polyuria and polydipsia may be seen if the cause is hyperadrenocorticism or hyperaldosteronism. 6) Systemic signs: Lethargy, depression, and altered mental status. In chronic cases, signs of the underlying disease (e.g., Cushing's syndrome: alopecia, pot-bellied appearance) may be present. Physical examination may reveal signs of dehydration (e.g., decreased skin turgor, dry mucous membranes), poor pulse quality, and weak femoral pulses. In severe cases, animals may be collapsed or comatose. It is important to note that clinical signs are often nonspecific, and a high index of suspicion is needed to diagnose metabolic alkalosis.

The differential diagnoses for metabolic alkalosis include other acid-base disorders and conditions that present with similar clinical signs. Key differentials include: 1) Respiratory alkalosis: Characterized by low PaCO2 and high pH, often due to hyperventilation (e.g., pain, anxiety, heatstroke). Blood gas analysis distinguishes this from metabolic alkalosis (which has high HCO3-). 2) Mixed acid-base disorders: For example, metabolic alkalosis with concurrent respiratory acidosis or metabolic acidosis. Careful evaluation of the anion gap and delta ratio is needed. 3) Hypokalemia: Can cause muscle weakness and arrhythmias, but is often a consequence of alkalosis rather than a primary differential. 4) Hypocalcemia: Can cause muscle tremors and seizures, but is also a consequence of alkalosis. 5) Hyperadrenocorticism: Presents with polyuria, polydipsia, and muscle weakness, and can cause metabolic alkalosis. 6) Primary hyperaldosteronism: Presents with hypertension, hypokalemia, and muscle weakness, and can cause metabolic alkalosis. 7) Chronic kidney disease: Can cause metabolic acidosis, but in some cases, may be associated with alkalosis due to vomiting or diuretic therapy. 8) Liver disease: Can cause respiratory alkalosis or metabolic alkalosis due to impaired urea synthesis. 9) Gastrointestinal obstruction: Causes vomiting and can lead to metabolic alkalosis. 10) Pancreatitis: Can cause vomiting and metabolic alkalosis. Definitive diagnosis requires blood gas analysis and measurement of serum electrolytes, urine chloride, and other parameters.

The diagnostic approach to metabolic alkalosis should be systematic and stepwise. 1) Initial assessment: Obtain a thorough history (including drug administration, vomiting episodes, and underlying diseases) and perform a complete physical examination. 2) Confirm the presence of metabolic alkalosis: Perform arterial or venous blood gas analysis. Metabolic alkalosis is defined by pH > 7.45, HCO3- > 26 mmol/L, and base excess > +4 mmol/L. Evaluate the PaCO2 to assess respiratory compensation (expected PaCO2 = 0.7 × HCO3- + 20 ± 5). 3) Evaluate serum electrolytes: Measure sodium, potassium, chloride, and calcium. Hypokalemia and hypochloremia are common. Calculate the anion gap (AG = Na+ - (Cl- + HCO3-)) to rule out concurrent metabolic acidosis. 4) Assess volume status: Clinical signs of dehydration, urine output, and blood pressure. 5) Determine urine chloride concentration: This is crucial to classify the alkalosis as chloride-responsive (urine Cl- < 20 mEq/L) or chloride-resistant (urine Cl- > 20 mEq/L). 6) Identify the underlying cause: Based on history, physical exam, and laboratory findings. For example, if vomiting is present, consider gastrointestinal disease; if the patient is on diuretics, consider drug-induced alkalosis; if hypertension and hypokalemia are present, consider hyperaldosteronism. 7) Additional testing: Depending on the suspected cause, perform abdominal ultrasound, endocrine testing (e.g., ACTH stimulation test for hyperadrenocorticism, aldosterone-to-renin ratio for hyperaldosteronism), or other specific tests. 8) Monitor response to therapy: Serial blood gas analysis and electrolyte measurements to guide treatment. This algorithm ensures a comprehensive evaluation and appropriate management.

Laboratory findings in metabolic alkalosis are characteristic. 1) Blood gas analysis: Arterial or venous blood gas shows pH > 7.45, HCO3- > 26 mmol/L, and base excess > +4 mmol/L. PaCO2 may be elevated due to compensatory hypoventilation (expected PaCO2 = 0.7 × HCO3- + 20 ± 5). 2) Serum biochemistry: Hypochloremia (Cl- < 105 mEq/L) is common due to loss of chloride in vomitus or urine. Hypokalemia (K+ < 3.5 mEq/L) is frequently present, especially in alkalosis due to mineralocorticoid excess or diuretics. Total calcium may be decreased due to increased protein binding, but ionized calcium is often normal. 3) Urinalysis: Urine pH may be alkaline (pH > 7.0) in the presence of bicarbonaturia, but in chloride-responsive alkalosis, urine pH may be acidic due to paradoxical aciduria. Urine chloride concentration is low (< 20 mEq/L) in chloride-responsive alkalosis and high (> 20 mEq/L) in chloride-resistant alkalosis. 4) Complete blood count: May show hemoconcentration (elevated PCV and total protein) if dehydration is present. 5) Additional biomarkers: Depending on the underlying cause, cortisol levels (for hyperadrenocorticism), aldosterone levels, or liver enzymes may be abnormal. 6) Electrocardiogram: May show changes consistent with hypokalemia (flattened T waves, U waves) or arrhythmias. These findings, combined with clinical history, help confirm the diagnosis and guide therapy.

Imaging studies are not typically used to diagnose metabolic alkalosis directly, but they are essential for identifying the underlying cause. 1) Abdominal radiography: May reveal gastric dilation, foreign bodies, or masses causing gastric outflow obstruction. In cases of hyperadrenocorticism, hepatomegaly and dystrophic mineralization of the skin or bronchi may be seen. 2) Thoracic radiography: Useful to evaluate for pulmonary disease that may cause respiratory compensation or concurrent respiratory acidosis. 3) Abdominal ultrasonography: Can identify adrenal gland enlargement (hyperadrenocorticism, hyperaldosteronism), liver disease, pancreatic masses, or gastrointestinal obstruction. 4) Echocardiography: May be indicated if cardiac disease is suspected, especially if arrhythmias are present. 5) Computed tomography (CT) or magnetic resonance imaging (MRI): May be used for detailed evaluation of the adrenal glands or pituitary gland in cases of hyperadrenocorticism. 6) Endoscopy: Can be used to evaluate the gastrointestinal tract for ulcers, foreign bodies, or neoplasia. Imaging findings are often nonspecific, but they are crucial for determining the etiopathogenesis and guiding treatment.

Cytology and histopathology are not typically used to diagnose metabolic alkalosis itself, but they are valuable for diagnosing underlying conditions. 1) Fine needle aspirate (FNA) of adrenal glands: May be performed if an adrenal mass is suspected. Cytology can help differentiate between adenoma, adenocarcinoma, and pheochromocytoma. 2) Liver biopsy: May be indicated if liver disease is suspected. Histopathology can reveal hepatic lipidosis, cirrhosis, or neoplasia. 3) Gastrointestinal biopsy: If inflammatory bowel disease or neoplasia is suspected as a cause of vomiting, endoscopic or surgical biopsies can provide a definitive diagnosis. 4) Renal biopsy: In cases of suspected primary renal tubular disorders, biopsy may be performed, though it is rarely necessary. Histopathological findings are specific to the underlying disease and are not used to confirm metabolic alkalosis. The diagnosis of metabolic alkalosis is based on blood gas analysis and electrolyte measurements.

Treatment of metabolic alkalosis should focus on correcting the underlying cause and restoring normal acid-base and electrolyte balance. 1) Emergency stabilization: If the patient is severely dehydrated or in shock, administer isotonic crystalloids (e.g., 0.9% sodium chloride) intravenously at a rate of 20-30 mL/kg over 15-30 minutes for dogs, and 10-20 mL/kg for cats, then reassess. 2) Fluid therapy: 0.9% sodium chloride is the fluid of choice because it provides chloride, which helps correct hypochloremia and promotes renal bicarbonate excretion. The rate of fluid administration should be tailored to the patient's hydration status and ongoing losses. 3) Potassium supplementation: If hypokalemia is present, add potassium chloride to the fluids. The maximum rate of potassium administration is 0.5 mEq/kg/hour, but this should be adjusted based on serum potassium levels. 4) Correction of the underlying cause: For vomiting, use antiemetics (e.g., maropitant 1 mg/kg SC q24h, or ondansetron 0.5-1 mg/kg IV q12h) and treat the primary gastrointestinal disease. If the cause is diuretic therapy, discontinue or reduce the diuretic. For hyperadrenocorticism, initiate treatment with trilostane (2-5 mg/kg PO q24h) or mitotane. For primary hyperaldosteronism, consider surgical removal of the adrenal mass or medical management with spironolactone (1-2 mg/kg PO q12h). 5) In severe cases, if the pH is > 7.55 and the patient is symptomatic, consider administration of acetazolamide (a carbonic anhydrase inhibitor) at a dose of 5-10 mg/kg IV or PO q8-12h, which increases renal bicarbonate excretion. 6) In rare cases of severe alkalosis refractory to therapy, dilute hydrochloric acid (0.1 N) can be administered via a central line, but this is rarely needed in veterinary practice. 7) Monitor electrolytes and blood gases frequently during treatment to avoid overcorrection. The goal is to gradually normalize pH and electrolytes.

The prognosis for metabolic alkalosis depends on the underlying cause and the severity of the condition. In general, if the underlying cause is identified and corrected, the prognosis is good. For example, metabolic alkalosis due to vomiting from dietary indiscretion or gastroenteritis typically resolves with fluid therapy and supportive care. However, if the alkalosis is due to a serious underlying disease such as hyperadrenocorticism or primary hyperaldosteronism, the prognosis is more guarded and depends on the response to treatment. Severe metabolic alkalosis (pH > 7.55) is associated with increased morbidity and mortality due to cardiac arrhythmias, seizures, and respiratory depression. Negative prognostic indicators include: 1) Severe hypokalemia (< 2.5 mEq/L) that is refractory to treatment. 2) Concurrent metabolic acidosis (mixed acid-base disorder). 3) Underlying renal or hepatic failure. 4) Lack of response to initial therapy within 24-48 hours. 5) Presence of severe clinical signs such as seizures or coma. With appropriate treatment, most patients recover within 2-5 days. Long-term prognosis is determined by the underlying disease process.

Follow-up care for patients with metabolic alkalosis is essential to ensure complete resolution and to monitor for recurrence. 1) Recheck blood gas analysis and serum electrolytes (sodium, potassium, chloride) within 24-48 hours after initiation of therapy, and then as needed until values normalize. 2) Monitor urine chloride concentration to confirm that the alkalosis is resolving. 3) If the underlying cause is vomiting, monitor for recurrence and adjust antiemetic therapy as needed. 4) If the cause is diuretic therapy, consider alternative medications or adjust dosages. 5) For endocrine disorders (e.g., hyperadrenocorticism), schedule regular rechecks (e.g., every 3-6 months) to monitor hormone levels and adjust medication dosages. 6) Provide dietary recommendations: For patients with hypokalemia, recommend a potassium-rich diet or potassium supplementation. 7) Educate owners on the importance of preventing dehydration and recognizing early signs of vomiting or electrolyte imbalance. 8) In chronic cases, periodic monitoring of renal function and blood pressure may be necessary. The frequency of follow-up should be individualized based on the underlying cause and the patient's response to treatment.

Clinical Pearls: 1) Always measure urine chloride in a patient with metabolic alkalosis; it is the single most useful test to guide therapy. 2) 0.9% sodium chloride is the fluid of choice for chloride-responsive alkalosis; it provides chloride and helps correct volume depletion. 3) Hypokalemia can perpetuate metabolic alkalosis; always correct potassium deficits aggressively, but do not exceed 0.5 mEq/kg/hour IV. 4) In patients with vomiting, use antiemetics early to reduce ongoing hydrogen ion loss. 5) Consider hyperadrenocorticism in any older dog with metabolic alkalosis, polyuria, polydipsia, and muscle weakness. 6) In cats, primary hyperaldosteronism is an important cause of metabolic alkalosis with hypokalemia and hypertension. Pitfalls: 1) Do not administer sodium bicarbonate to a patient with metabolic alkalosis; this will worsen the alkalosis. 2) Avoid overzealous fluid therapy with balanced electrolyte solutions (e.g., lactated Ringer's) in chloride-responsive alkalosis, as they may not provide enough chloride. 3) Do not ignore hypokalemia; failure to correct it will make the alkalosis refractory to treatment. 4) Do not assume that all alkalosis is chloride-responsive; measure urine chloride to differentiate. 5) In patients with chronic respiratory acidosis, rapid correction of hypercapnia can lead to post-hypercapnic alkalosis; wean ventilatory support gradually. 6) Be cautious with acetazolamide in patients with hepatic or renal disease, as it can cause metabolic acidosis and electrolyte imbalances.

Drug protocols for metabolic alkalosis are primarily supportive and aimed at correcting the underlying cause. 1) Fluid therapy: 0.9% sodium chloride (NaCl) is the crystalloid of choice. For dogs: initial bolus 20-30 mL/kg IV over 15-30 minutes, then maintenance rate 40-60 mL/kg/day, adjusted for ongoing losses. For cats: initial bolus 10-20 mL/kg IV over 15-30 minutes, then maintenance rate 40-60 mL/kg/day. 2) Potassium chloride (KCl) supplementation: Add to fluids at a rate of 20-40 mEq/L of fluid, but do not exceed 0.5 mEq/kg/hour IV. Recheck serum potassium every 4-6 hours during supplementation. 3) Antiemetics: Maropitant (Cerenia) 1 mg/kg SC q24h for up to 5 days; or Ondansetron 0.5-1 mg/kg IV q12h; or Metoclopramide 1-2 mg/kg/day IV CRI. 4) Acetazolamide (Diamox) for severe alkalosis (pH > 7.55): 5-10 mg/kg IV or PO q8-12h, but use with caution in patients with hepatic or renal disease. 5) For hyperadrenocorticism: Trilostane (Vetoryl) 2-5 mg/kg PO q24h, adjust based on ACTH stimulation test; or Mitotane (Lysodren) 50 mg/kg/day PO for 7-10 days, then 50 mg/kg/week. 6) For primary hyperaldosteronism: Spironolactone 1-2 mg/kg PO q12h; or surgical adrenalectomy. 7) For gastric outflow obstruction: Surgical correction may be necessary; preoperatively, manage with fluid therapy and antiemetics. 8) For diuretic-induced alkalosis: Discontinue or reduce the diuretic; if continued diuresis is needed, consider potassium-sparing diuretics (e.g., spironolactone). Always consult Plumb's Veterinary Drug Handbook for detailed dosing and contraindications.

Evidence-based literature on metabolic alkalosis in veterinary medicine is limited, but several key studies and reviews provide guidance. 1) A study by DiBartola (2012) in 'Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice' provides a comprehensive review of acid-base physiology and metabolic alkalosis, emphasizing the importance of urine chloride in classification. 2) A retrospective study by Hopper et al. (2014) in the Journal of Veterinary Emergency and Critical Care evaluated acid-base disorders in critically ill dogs and found that metabolic alkalosis was present in 15% of cases, often associated with vomiting and diuretic therapy. 3) A study by de Morais and Leisewitz (2015) in the Veterinary Clinics of North America discussed the pathophysiology and treatment of metabolic alkalosis, highlighting the role of hypokalemia and hypochloremia in perpetuating the disorder. 4) Consensus guidelines from the American College of Veterinary Internal Medicine (ACVIM) on hyperadrenocorticism (2018) recommend monitoring acid-base status in affected dogs, as metabolic alkalosis is a common complication. 5) A study by Reusch (2015) on feline hyperaldosteronism reported that metabolic alkalosis is a frequent finding in affected cats, and treatment with spironolactone or surgery can resolve the alkalosis. 6) A review by Bateman (2013) in the Journal of Veterinary Emergency and Critical Care summarized the use of acetazolamide in veterinary patients, noting its efficacy in treating metabolic alkalosis but cautioning about potential side effects. Overall, the literature supports a systematic approach to diagnosis and treatment, with emphasis on correcting the underlying cause and electrolyte imbalances.